Mirna-22 Deletion Limits White Adipose Expansion and Activates Brown Fat to Attenuate High-Fat Diet-Induced Fat Mass Accumulation

Vanessa M. Lima,Jianming Liu,Bruna B. Brandao,Caroline A. Lino,Camila S. Balbino Silva,Marcio A. C. Ribeiro,Tiago E. Oliveira,Caroline C. Real,Daniele de Paula Faria,Carly Cederquist,Zhan-Peng Huang,Xiaoyun Hu,Maria Luiza Barreto-Chaves,Julio C. B. Ferreira,William T. Festuccia,Marcelo A. Mori,C. Ronald Kahn,Da-Zhi Wang,Gabriela P. Diniz

DOI: https://doi.org/10.1016/j.metabol.2021.154723

2021-01-01

Abstract:Background: Obesity, characterized by excessive expansion of white adipose tissue (WAT), is associated with numerous metabolic complications. Conversely, brown adipose tissue (BAT) and beige fat are thermogenic tissues that protect mice against obesity and related metabolic disorders. We recently reported that deletion of miR-22 enhances energy expenditure and attenuates WAT expansion in response to a high-fat diet (HFD). However, the molecular mechanisms involved in these effects mediated by miR-22 loss are unclear. Methods and Results: Here, we show that miR-22 expression is induced during white, beige, and brown adipocyte differentiation in vitro. Deletion of miR-22 reduced white adipocyte differentiation in vitro. Loss of miR-22 prevented HFD-induced expression of adipogenic/lipogenic markers and adipocyte hypertrophy in murine WAT. In addition, deletion of miR-22 protected mice against HFD-induced mitochondrial dysfunction in WAT and BAT. Loss of miR-22 induced WAT browning. Gain-and loss-of-function studies revealed that miR-22 did not affect brown adipogenesis in vitro. Interestingly, miR-22 KO mice fed a HFD displayed increased expression of genes involved in thermogenesis and adrenergic signaling in BAT when compared to WT mice fed the same diet. Conclusions: Collectively, our findings suggest that loss of miR-22 attenuates fat accumulation in response to a HFD by reducing white adipocyte differentiation and increasing BAT activity, reinforcing miR-22 as a potential therapeutic target for obesity-related disorders. (c) 2021 Elsevier Inc. All rights reserved.